Smith & Nephew (SNN) Cash from Discontinued Operations (2009 - 2024)

Smith & Nephew (SNN) posted quarterly Cash from Discontinued Operations of 238000000.0 for Q4 2024, up 110.62% year-on-year from 113000000.0 in Q1 2024, and up 110.62% on a QoQ basis from 113000000.0 in Q4 2023.

Smith & Nephew (SNN) Cash from Discontinued Operations (2009 - 2024) Analysis & Trends

Smith & Nephew (SNN) has reported Cash from Discontinued Operations for 16 consecutive years, with 238000000.0 the latest figure, recorded in Q4 2024.

  • Quarterly Cash from Discontinued Operations rose 110.62% year-over-year to 238000000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 921000000.0 (up 21.83% YoY) and the FY2025 annual result came in at 1285000000.0, up 30.19% from the prior year.
  • Cash from Discontinued Operations climbed to 238000000.0 in Q4 2024 per SNN's latest filing, from 113000000.0 in the prior quarter.
  • Over the last five years, Cash from Discontinued Operations for SNN reached as high as 363000000.0 in Q4 2021 and fell as low as 73000000.0 in Q4 2020.
  • A 5-year average of 198800000.0 and a median of 207000000.0 in 2022 frame the typical range for Cash from Discontinued Operations.
  • Annual changes were most pronounced in 2020 — Cash from Discontinued Operations slumped 83.81% — and 2021, when it jumped 397.26%.
  • Year by year, Cash from Discontinued Operations stood at 73000000.0 in 2020, then soared by 397.26% to 363000000.0 in 2021, then tumbled by 42.98% to 207000000.0 in 2022, then slumped by 45.41% to 113000000.0 in 2023, then surged by 110.62% to 238000000.0 in 2024.
  • According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 238000000.0, 113000000.0, and 207000000.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 238.00 Mn
Dec 31, 2024 238.00 Mn
Dec 31, 2023 113.00 Mn
Dec 31, 2023 113.00 Mn
Dec 31, 2022 207.00 Mn
Dec 31, 2022 207.00 Mn
Dec 31, 2021 363.00 Mn
Dec 31, 2021 363.00 Mn
Dec 31, 2020 73.00 Mn
Dec 31, 2020 73.00 Mn
Dec 31, 2019 451.00 Mn
Dec 31, 2019 451.00 Mn
Dec 31, 2018 931.00 Mn
Dec 31, 2018 931.00 Mn
Dec 31, 2017 1.09 Bn
Dec 31, 2017 1.09 Bn
Dec 31, 2016 269.00 Mn
Dec 31, 2016 269.00 Mn
Dec 31, 2015 490.00 Mn
Dec 31, 2015 490.00 Mn